Th3 Immune responses in the progression of leprosy via molecular cross-talks of TGF-β, CTLA-4 and Cbl-b

Clinical Immunology

Volumn 141, Issue 2, 2011, Pages 133-142

  Kumar, Sudhir ^a   Naqvi, Raza A ^a   Khanna, Neena ^a   Pathak, Pankaj ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Leprosy; MLCwA; Mycobacterium leprae; TGF ; Th3

Indexed keywords

CBL PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRACELLULAR SIGNALING; LEPROSY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; TH2 CELL; TH3 CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; CELL LINEAGE; CELL WALL; CELLS, CULTURED; CTLA-4 ANTIGEN; CYTOKINES; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; LEPROSY, MULTIBACILLARY; LEPROSY, PAUCIBACILLARY; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM LEPRAE; PROTO-ONCOGENE PROTEINS C-CBL; RNA, SMALL INTERFERING; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 80054831920     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.06.007     Document Type: Article

References (22)

1. Scollard D.M., Adams L.B., Gillis T.P., Krahenbuhl R.W., Truman, Williams D.L. The continuing challenges of leprosy. Clin. Microbiol. Rev. 2006, 19:338-381.
2. Ridley D.S., Jopling W.H. Classification of leprosy according to immunity: a five-group system. Int. J. Lepr. Other Mycobact. Dis. 1966, 34:255-273.
3. Modlin R.L. Th1-Th2 paradigm: insights from leprosy. J. Investig. Dermatol. 1994, 102:828-832.
4. Sridevi K., Khanna N., Chattree V., Pal P.C., Haq W., Rao D.N. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposome delivery. Int. Immunopharmacol. 2003, 3:1589-1600.
5. Sridevi K., Khanna N., Chitralekha T., Arif A.K., Tomar D., Rao D.N. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients usingMycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein. Int. Immunopharmacol. 2004, 4:1-14.
6. Carvalho K.I., Maeda S., Marti L., Yamashita J., Haslett P.A., Kallas E.G. Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects. Immunology 2008, 124:206-214.
7. Kumar S., Naqvi R.A., Khanna N., Rao D.N. Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy. Mol. Immunol. 2011, 48:1178-1190.
8. Jean-Marc G., Paul-Henri R. T-cell expression of the human GATA-3 gene: is regulated by a non-lineage-specific silencer. J. Biol. Chem. 1999, 274:6567-6578.
9. Jinfang Z. Transcriptional regulation of Th2 cell differentiation. Immunol. Cell Biol. 2010, 88:244-249.
10. H1 differentiation. Nat. Immunol. 2008, 9:9-10.
11. Flavell R.A., Sanjabi S., Wrzesinski S.H., Licona-Limón P. The polarization of immune cells in the tumour environment by TGF-β. Nat. Rev. Immunol. 2010, 10:554-567.
12. Lahdenperä A., Ludvigsson J., Fälth-Magnusson K., Högberg L., Vaarala O. The effect of gluten-free diet on Th1/Th2/Th3-associated intestinal immune responses in celiac disease. Scand. J Gastroenterol. Feb 3, 2011, [Epub ahead of print].
13. Rezende M.M., Hassing I., Bol-Schoenmakers M., Bleumink R., Boon L., van Bilsen J., Pieters R. CD4 (+) CD25 (+) T regulatory cells do not transfer oral tolerance to peanut allergens in a mouse model of peanut allergy. Clin. Exp. Immunol. Mar 17, 2011, [Epub ahead of print]. 10.1111/j.1365-2249.2011.04334.x.
14. Yang L., Pang Y., Moses H.L. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trend Immunol. 2010, 31:220-227.
15. Vock C., Hauber H.P., Wegmann M. The other T helper cells in asthma pathogenesis. J. Allergy 2010, 519298 (Epub 2010 Jul 25).
16. Pentcheva-Hoang T., Egen J.G., Wojnoonski K., Allison J.P. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004, 21:401-413.
17. Baniyash M. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 2004, 4:675-687.
18. Rao N., Ghosh A.K., Ota S., Zhou P., Reddi A.L., Hakezi K., Druker B.K., Wu J., Band H. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J. 2001, 20:7085-7095.
19. Rao N., Miyake S., Reddi A.L., Douillard P., Ghosh A.K., Dodge I.L., Zhou P., Fernandes N.D., Band H. Negative regulation of Lck by Cbl ubiquitin ligase. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3794-3799.
20. Boyum A. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Investig. 1968, 21:77-89.
21. Qureshi O.S., Zheng Y., Nakamura K., Attridge K., Manzotti C., Schmidt E.M., Baker J., Jeffery L.E., Kaur S., Briggs Z., Hou T.Z., Futter C.E., Anderson G., Walker L.S., Sansom D.M. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011, 332:600-603. Epub 2011 Apr 7.
22. Laskowski I.A., Pratschke J., Wilhelm M.J., Dong V.M., Beato F., Taal M., Gasser M., Hancock W.W., Sayegh M.H., Tilney N.L. Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J. Am. Soc. Nephrol. 2002, 13:519-527.